Article Details

Antheia Raises $56M Series C to Alleviate Global Drug Shortages with Synthetic Biology

Retrieved on: 2025-06-03 16:10:10

Tags for this article:

Click the tags to see associated articles and topics

Antheia Raises $56M Series C to Alleviate Global Drug Shortages with Synthetic Biology. View article details on hiswai:

Excerpt

Antheia has raised $56 million in a Series C financing round to accelerate its synthetic biology platform, which harnesses engineered yeast to ...

Article found on: www.synbiobeta.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo